SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001274644-16-000134
Filing Date
2016-09-21
Accepted
2016-09-21 16:08:33
Documents
3
Period of Report
2016-09-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K- OCERA ANNOUNCES STOP-ALF ENROLLMENT COMPLETION ocera-8xkitem80192116.htm 8-K 32323
2 EXHIBIT 99.1 - PRESS RELEASE oceraannouncesstop-alfenro.htm EX-99.1 13201
3 oceraannouncesstopalf_image1.jpg GRAPHIC 11182
  Complete submission text file 0001274644-16-000134.txt   62116
Mailing Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301
Business Address 525 UNIVERSITY AVENUE SUITE 610 PALO ALTO CA 94301 6504625800
Ocera Therapeutics, Inc. (Filer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35119 | Film No.: 161895730
SIC: 2834 Pharmaceutical Preparations